However, the AHR also has been reported to exhibit anti-tumorigenic effects in prostate [30], stomach [31] liver [9] pancreatic [32] and breast [33,87,88,89,90] cancers, suggesting that full or partial AHR agonists might be the more appropriate cancer therapeutic. The gene discussed is AHR; the disease is cancer.